Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
330.60    -3.80 (-1.14%)
Bid:
329.60
Ask:
330.80
Spread: 1.20 (0.364%)
Market Cap: £1.75b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Total Voting Rights

5 Aug 2025 08:15

RNS Number : 9188T
Hammerson PLC
05 August 2025
 

Hammerson Plc(the "Company" or "Hammerson")

Total Voting Rights and Capital

5 August 2025

The Company confirms that, following the successful non-pre-emptive placing of a total of 48,253,994 ordinary shares of 5 pence each (the "Placing Shares") in the capital of the Company as announced on 31 July 2025, a total of 32,080,390 ordinary shares (the "UK Placing Shares") were admitted to trading on the main market for listed securities of the London Stock Exchange plc and the main market for listed securities of Euronext Dublin on 5 August 2025.

As announced on 31 July 2025, subject to receipt of approval to inward list the Placing Shares from the Financial Surveillance Department of the South African Reserve Bank ("SARB Approval"), applications will be made: (i) for those 16,173,604 Placing Shares placed with placees who are South African Qualifying Investors (the "SA Placing Shares") to be admitted to (a) listing in the Equity Shares (Commercial Companies) category of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc; and (b) listing on the Official List of The Irish Stock Exchange plc, trading as Euronext Dublin and to trading on the main market for listed securities of Euronext Dublin; and (ii) for the Placing Shares to be admitted to listing and trading as a secondary inward listing on the Main Board of the securities exchange operated by the JSE Limited. The application for SARB Approval was submitted on 29 July 2025 and it is expected that confirmation as to whether SARB Approval has been obtained will be known no later than the end of August. Further announcements will be made by the Company at the appropriate time, as and when required.

In accordance with the requirements of the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, the Company hereby notifies the market that the Company's issued share capital as of Tuesday, 5 August 2025, consists of 515,992,168 ordinary shares, of which 1,300,825 shares are held in treasury. Therefore, the total number of voting rights in the Company as of Tuesday, 5 August 2025 is 514,691,343. This figure should be used by shareholders as the denominator for calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, ordinary shares in the Company, under the Disclosure and Transparency Rules and/or the Irish Transparency (Directive 2004/109/EC) Regulations 2007, as amended.

For further information contact:

Richard Crowle

Deputy Company Secretary

+44 (0) 20 7887 1000

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRPKQBPABKDBFK
Date   Source Headline
27th Jul 20234:30 pmRNSInterim Dividend Record Date Correction
27th Jul 20237:01 amRNSDividend Declaration
27th Jul 20237:00 amRNSHalf-year Report
5th Jul 20237:00 amRNSNotice of Results & IASB Accounting Interpretation
22nd Jun 202311:30 amRNSHolding(s) in Company
22nd Jun 20237:00 amRNSHolding(s) in Company
14th Jun 20239:30 amRNSHolding(s) in Company
12th Jun 20231:15 pmRNSHolding(s) in Company
31st May 20239:00 amRNSBlock listing Interim Review
30th May 202311:30 amRNSHolding(s) in Company
17th May 20239:00 amRNSDirector/PDMR Shareholding
4th May 20234:15 pmRNSResult of AGM
28th Apr 20234:15 pmRNSDirector/PDMR Shareholding
26th Apr 20233:30 pmRNSHolding(s) in Company
25th Apr 20237:00 amRNSPre AGM trading update
17th Apr 20234:00 pmRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
13th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:00 amRNSAnnual Report and Notice of Annual General Meeting
3rd Apr 20237:00 amRNSDisposal
21st Mar 20235:15 pmRNSDirector/PDMR Shareholding
10th Mar 202311:45 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSFinal Results
6th Mar 20233:30 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSIASB Accounting Interpretation
16th Jan 20233:00 pmRNSNotice of Results and Registered Office Change
30th Nov 202210:00 amRNSBlock listing Interim Review
23rd Nov 202212:45 pmRNSShare capital reduction confirmation
22nd Nov 202212:30 pmRNSHolding(s) in Company
10th Nov 20228:00 amRNSDirector/PDMR Shareholding
8th Nov 20223:45 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSQ3 trading, operational and rent collection update
3rd Nov 20227:43 amRNSTotal Voting Rights
3rd Nov 20227:00 amRNS2023 EUR500,000,000 1.750 per cent Bond Redemption
1st Nov 20229:45 amRNSInterim Dividend and Enhanced Scrip Alternative
25th Oct 20222:30 pmRNSResult of General Meeting
19th Oct 202210:45 amRNSBoard Committee Appointment
12th Oct 20227:00 amRNSDirectorate Change
6th Oct 20224:00 pmRNSHolding(s) in Company
6th Oct 202210:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Sep 20224:30 pmRNSHolding(s) in Company
28th Sep 202210:00 amRNSCircular, Notice of Meeting and Form of Proxy
27th Sep 20229:30 amRNSCurrency Conversion & Scrip Reference Share Price
14th Sep 20224:00 pmRNSInterim 2022 Dividend Expected Timetable of Events
18th Aug 202212:15 pmRNSHolding(s) in Company
28th Jul 20227:01 amRNSDividend Declaration
28th Jul 20227:00 amRNSHalf-year Report
14th Jul 202212:15 pmRNSDirector/PDMR Shareholding
11th Jul 20221:00 pmRNSDirector/PDMR Shareholding
28th Jun 202210:45 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.